Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversal of Cognitive Decline (ReCODE) Study

NCT03883633 is registered in ClinicalTrials.gov with QuesGen Systems Inc as lead sponsor.

NCT NCT03883633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03883633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversal of Cognitive Decline (ReCODE) Study
Lead sponsor
QuesGen Systems Inc
Phase
Observational
Overall status
Completed
Start date
June 30, 2019
Completion date
December 31, 2020
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment